TI
STOK icon

Trexquant Investment’s Stoke Therapeutics STOK Stock Holding History

Trexquant Investment’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-86,140
Closed -$573K – 1865
2025
Q1 		$573K Sell
86,140
-16,891
-16% -$157K 0.01% 1243
2024
Q4 		$1.14M Sell
103,031
-58,718
-36% -$721K 0.01% 1057
2024
Q3 		$1.99M Sell
161,749
-17,864
-10% -$253K 0.03% 816
2024
Q2 		$2.43M Buy
179,613
+148,637
+480% +$2.01M 0.04% 668
2024
Q1 		$418K Sell
30,976
-8,824
-22% -$53.5K 0.01% 1201
2023
Q4 		$209K Sell
39,800
-87,781
-69% -$375K ﹤0.01% 1327
2023
Q3 		$503K Buy
127,581
+79,785
+167% +$525K 0.01% 1020
2023
Q2 		$508K Sell
47,796
-77,829
-62% -$828K 0.01% 993
2023
Q1 		$1.05M Buy
125,625
+38,096
+44% +$344K 0.03% 713
2022
Q4 		$808K Buy
87,529
+37,673
+76% +$392K 0.02% 733
2022
Q3 		$640K Sell
49,856
-33,801
-40% -$539K 0.02% 707
2022
Q2 		$1.1M Buy
83,657
+67,511
+418% +$1.03M 0.05% 473
2022
Q1 		$340K Sell
16,146
-10,253
-39% -$205K 0.02% 943
2021
Q4 		$633K Buy
+26,399
New +$630K 0.04% 545
2021
Q3 		– Sell
-8,949
Closed -$301K – 1471
2021
Q2 		$301K Buy
8,949
+1,053
+13% +$37.2K 0.03% 714
2021
Q1 		$307K Buy
+7,896
New +$450K 0.03% 741

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trexquant Investment's STOK Position: Q2 2025 in Review

Trexquant Investment sold out of Stoke Therapeutics (STOK) in Q2 2025, closing a stake of 86,140 shares — an estimated $573K sold.

Trexquant Investment first reported a position in STOK in Q1 2021 and held it in 16 quarters. The position peaked at $2.43M in Q2 2024. 133 funds tracked by Wall St. Rank hold STOK as of Q2 2025.

  • Trexquant Investment reported no remaining Stoke Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 86,140 Stoke Therapeutics shares in Q2 2025, an estimated $573K.
  • Trexquant Investment first reported a position in Stoke Therapeutics in Q1 2021 and held it in 16 quarters.
  • Trexquant Investment's Stoke Therapeutics position peaked at $2.43M in Q2 2024.
  • 133 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.